UniProt ID | NFKB1_HUMAN | |
---|---|---|
UniProt AC | P19838 | |
Protein Name | Nuclear factor NF-kappa-B p105 subunit | |
Gene Name | NFKB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 968 | |
Subcellular Localization | Nucleus. Cytoplasm. Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). | |
Protein Description | NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.. | |
Protein Sequence | MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Phosphorylation | QMFHLDPSLTHTIFN HHCCCCCCCCCEECC | 45.63 | 20966071 | |
59 | Phosphorylation | QRGFRFRYVCEGPSH HCCCCEEEEECCCCC | 13.52 | 18083107 | |
61 | S-nitrosocysteine | GFRFRYVCEGPSHGG CCCEEEEECCCCCCC | 3.57 | - | |
61 | Glutathionylation | GFRFRYVCEGPSHGG CCCEEEEECCCCCCC | 3.57 | 22833525 | |
61 | Other | GFRFRYVCEGPSHGG CCCEEEEECCCCCCC | 3.57 | 11466314 | |
61 | S-nitrosylation | GFRFRYVCEGPSHGG CCCEEEEECCCCCCC | 3.57 | 8710491 | |
73 | Phosphorylation | HGGLPGASSEKNKKS CCCCCCCCCCCCCCC | 44.97 | 28348404 | |
74 | Phosphorylation | GGLPGASSEKNKKSY CCCCCCCCCCCCCCC | 52.64 | 28857561 | |
80 | Phosphorylation | SSEKNKKSYPQVKIC CCCCCCCCCCCEEEC | 43.59 | 24905233 | |
81 | Phosphorylation | SEKNKKSYPQVKICN CCCCCCCCCCEEECC | 13.43 | 24905233 | |
116 | Acetylation | HAHSLVGKHCEDGIC EEHHHHCCCCCCCEE | 37.29 | 26051181 | |
147 | Ubiquitination | GILHVTKKKVFETLE EEEEECHHHHHHHHH | 44.82 | 29967540 | |
148 | Ubiquitination | ILHVTKKKVFETLEA EEEECHHHHHHHHHH | 54.43 | 29967540 | |
149 | Ubiquitination | LHVTKKKVFETLEAR EEECHHHHHHHHHHH | 7.81 | 29967540 | |
165 | Phosphorylation | TEACIRGYNPGLLVH HHHHHHCCCCCCEEC | 14.34 | - | |
205 | Ubiquitination | QAALQQTKEMDLSVV HHHHHHHHHCCHHHH | 46.86 | 24816145 | |
206 | Ubiquitination | AALQQTKEMDLSVVR HHHHHHHHCCHHHHH | 41.12 | 24816145 | |
213 | Ubiquitination | EMDLSVVRLMFTAFL HCCHHHHHHHHHHHC | 20.48 | 24816145 | |
223 | Phosphorylation | FTAFLPDSTGSFTRR HHHHCCCCCCCCCCC | 32.50 | - | |
228 | Phosphorylation | PDSTGSFTRRLEPVV CCCCCCCCCCCCCCC | 19.31 | - | |
240 | Phosphorylation | PVVSDAIYDSKAPNA CCCCCHHCCCCCCCC | 18.84 | 20090780 | |
241 | Phosphorylation | VVSDAIYDSKAPNAS CCCCHHCCCCCCCCC | 37.23 | 25147952 | |
242 | Phosphorylation | VSDAIYDSKAPNASN CCCHHCCCCCCCCCC | 17.47 | - | |
243 | Ubiquitination | SDAIYDSKAPNASNL CCHHCCCCCCCCCCC | 66.03 | 29967540 | |
244 | Ubiquitination | DAIYDSKAPNASNLK CHHCCCCCCCCCCCE | 13.41 | 29967540 | |
251 | Acetylation | APNASNLKIVRMDRT CCCCCCCEEEEECCC | 43.32 | 25953088 | |
251 | Malonylation | APNASNLKIVRMDRT CCCCCCCEEEEECCC | 43.32 | 26320211 | |
251 | Ubiquitination | APNASNLKIVRMDRT CCCCCCCEEEEECCC | 43.32 | 29967540 | |
252 | Ubiquitination | PNASNLKIVRMDRTA CCCCCCEEEEECCCC | 2.40 | 29967540 | |
252 (in isoform 2) | Ubiquitination | - | 2.40 | - | |
277 | Malonylation | LLCDKVQKDDIQIRF EEECCCCCCCCEEEE | 61.43 | 26320211 | |
301 | Phosphorylation | WEGFGDFSPTDVHRQ CCCCCCCCCCHHHHC | 31.46 | 28348404 | |
302 | Phosphorylation | EGFGDFSPTDVHRQF CCCCCCCCCHHHHCE | 32.39 | 27251275 | |
304 | Ubiquitination | FGDFSPTDVHRQFAI CCCCCCCHHHHCEEE | 37.29 | 24816145 | |
324 | Phosphorylation | KYKDINITKPASVFV CCCCCCCCCCHHHEE | 26.87 | - | |
325 | Sumoylation | YKDINITKPASVFVQ CCCCCCCCCHHHEEE | 34.49 | - | |
325 | Sumoylation | YKDINITKPASVFVQ CCCCCCCCCHHHEEE | 34.49 | 28112733 | |
328 | Phosphorylation | INITKPASVFVQLRR CCCCCCHHHEEEEEE | 25.31 | 22152481 | |
337 | Phosphorylation | FVQLRRKSDLETSEP EEEEEEHHCCCCCCC | 45.69 | 12947093 | |
345 | Ubiquitination | DLETSEPKPFLYYPE CCCCCCCCCCCCCCC | 44.33 | 29967540 | |
346 | Ubiquitination | LETSEPKPFLYYPEI CCCCCCCCCCCCCCC | 34.88 | 29967540 | |
356 | Ubiquitination | YYPEIKDKEEVQRKR CCCCCCCHHHHHHHH | 51.26 | 24816145 | |
357 | Ubiquitination | YPEIKDKEEVQRKRQ CCCCCCHHHHHHHHH | 73.80 | 24816145 | |
364 | Ubiquitination | EEVQRKRQKLMPNFS HHHHHHHHHHCCCCC | 46.39 | 24816145 | |
371 | Phosphorylation | QKLMPNFSDSFGGGS HHHCCCCCCCCCCCC | 38.70 | 28348404 | |
373 | Phosphorylation | LMPNFSDSFGGGSGA HCCCCCCCCCCCCCC | 25.29 | 28348404 | |
378 | Phosphorylation | SDSFGGGSGAGAGGG CCCCCCCCCCCCCCC | 28.83 | 28348404 | |
379 | Phosphorylation | DSFGGGSGAGAGGGG CCCCCCCCCCCCCCC | 31.16 | 27251275 | |
390 | Phosphorylation | GGGGMFGSGGGGGGT CCCCCCCCCCCCCCC | 24.01 | 28348404 | |
397 | Phosphorylation | SGGGGGGTGSTGPGY CCCCCCCCCCCCCCC | 31.10 | 28348404 | |
399 | O-linked_Glycosylation | GGGGGTGSTGPGYSF CCCCCCCCCCCCCCC | 29.99 | 23301498 | |
399 | Phosphorylation | GGGGGTGSTGPGYSF CCCCCCCCCCCCCCC | 29.99 | 28348404 | |
400 | Phosphorylation | GGGGTGSTGPGYSFP CCCCCCCCCCCCCCC | 49.06 | 28348404 | |
409 | Phosphorylation | PGYSFPHYGFPTYGG CCCCCCCCCCCCCCC | 22.24 | - | |
413 | Phosphorylation | FPHYGFPTYGGITFH CCCCCCCCCCCEEEC | 32.32 | - | |
423 | O-linked_Glycosylation | GITFHPGTTKSNAGM CEEECCCCCCCCCCC | 35.19 | 23301498 | |
431 | Acetylation | TKSNAGMKHGTMDTE CCCCCCCCCCCCCCC | 37.66 | 11739381 | |
435 | Sulfoxidation | AGMKHGTMDTESKKD CCCCCCCCCCCCCCC | 7.70 | 30846556 | |
440 | Acetylation | GTMDTESKKDPEGCD CCCCCCCCCCCCCCC | 55.77 | 11739381 | |
440 | Ubiquitination | GTMDTESKKDPEGCD CCCCCCCCCCCCCCC | 55.77 | 10207090 | |
441 | Acetylation | TMDTESKKDPEGCDK CCCCCCCCCCCCCCC | 83.93 | 11739381 | |
441 | Ubiquitination | TMDTESKKDPEGCDK CCCCCCCCCCCCCCC | 83.93 | 10207090 | |
449 | Phosphorylation | DPEGCDKSDDKNTVN CCCCCCCCCCCCCEE | 37.48 | - | |
452 | Ubiquitination | GCDKSDDKNTVNLFG CCCCCCCCCCEECCC | 60.55 | 22817900 | |
485 | Phosphorylation | NGEVTLTYATGTKEE CCEEEEEEEECCCCC | 12.79 | - | |
504 | Ubiquitination | QDNLFLEKAMQLAKR CCCHHHHHHHHHHHH | 51.83 | 21906983 | |
504 (in isoform 1) | Ubiquitination | - | 51.83 | 21906983 | |
505 | Ubiquitination | DNLFLEKAMQLAKRH CCHHHHHHHHHHHHH | 4.99 | 22817900 | |
505 (in isoform 2) | Ubiquitination | - | 4.99 | 21906983 | |
512 | Ubiquitination | AMQLAKRHANALFDY HHHHHHHHHHHHHHH | 23.72 | 22817900 | |
519 | Phosphorylation | HANALFDYAVTGDVK HHHHHHHHHHHHCHH | 8.81 | 28796482 | |
520 | Phosphorylation | ANALFDYAVTGDVKM HHHHHHHHHHHCHHH | 8.34 | 27642862 | |
582 | Phosphorylation | INMRNDLYQTPLHLA HHCCCCCCCCCCEEE | 17.13 | - | |
584 | Phosphorylation | MRNDLYQTPLHLAVI CCCCCCCCCCEEEEE | 17.79 | - | |
624 | Ubiquitination | SVLHLAAKEGHDKVL HHHHHHHHCCCHHHH | 59.63 | 29967540 | |
625 | Ubiquitination | VLHLAAKEGHDKVLS HHHHHHHCCCHHHHH | 57.97 | 29967540 | |
625 (in isoform 2) | Ubiquitination | - | 57.97 | - | |
678 | Hydroxylation | VAAGADVNAQEQKSG HHHCCCCCHHHHHHC | 36.13 | 17003112 | |
759 | Phosphorylation | PLYDLDDSWENAGED CCCCCCCHHHHCCCC | 35.64 | - | |
764 | Ubiquitination | DDSWENAGEDEGVVP CCHHHHCCCCCCCCC | 55.24 | 22817900 | |
769 | Ubiquitination | NAGEDEGVVPGTTPL HCCCCCCCCCCCCCC | 4.40 | 22817900 | |
804 | Ubiquitination | FTSDDLLAQGDMKQL CCHHHHHHCCCHHHH | 20.71 | 21963094 | |
816 | Ubiquitination | KQLAEDVKLQLYKLL HHHHHHHHHHHHHHH | 42.72 | 22817900 | |
817 | Ubiquitination | QLAEDVKLQLYKLLE HHHHHHHHHHHHHHC | 4.21 | 22817900 | |
817 (in isoform 2) | Ubiquitination | - | 4.21 | - | |
821 | Ubiquitination | DVKLQLYKLLEIPDP HHHHHHHHHHCCCCC | 56.01 | 21906983 | |
821 (in isoform 1) | Ubiquitination | - | 56.01 | 21906983 | |
822 | Ubiquitination | VKLQLYKLLEIPDPD HHHHHHHHHCCCCCC | 3.07 | 22817900 | |
822 (in isoform 2) | Ubiquitination | - | 3.07 | 21906983 | |
824 | Ubiquitination | LQLYKLLEIPDPDKN HHHHHHHCCCCCCCC | 64.01 | 22817900 | |
829 | Ubiquitination | LLEIPDPDKNWATLA HHCCCCCCCCHHHHH | 65.39 | 22817900 | |
830 | Ubiquitination | LEIPDPDKNWATLAQ HCCCCCCCCHHHHHH | 60.83 | 29967540 | |
831 | Ubiquitination | EIPDPDKNWATLAQK CCCCCCCCHHHHHHH | 40.78 | 29967540 | |
831 (in isoform 2) | Ubiquitination | - | 40.78 | - | |
851 | Phosphorylation | LNNAFRLSPAPSKTL HCCCHHCCCCCCCCC | 18.11 | 25159151 | |
852 | Phosphorylation | NNAFRLSPAPSKTLM CCCHHCCCCCCCCCC | 53.43 | 24719451 | |
855 | Phosphorylation | FRLSPAPSKTLMDNY HHCCCCCCCCCCCCE | 40.14 | 23403867 | |
856 | Ubiquitination | RLSPAPSKTLMDNYE HCCCCCCCCCCCCEE | 44.62 | 27667366 | |
856 (in isoform 1) | Ubiquitination | - | 44.62 | 21906983 | |
857 | Phosphorylation | LSPAPSKTLMDNYEV CCCCCCCCCCCCEEE | 31.49 | 28796482 | |
857 | Ubiquitination | LSPAPSKTLMDNYEV CCCCCCCCCCCCEEE | 31.49 | 27667366 | |
857 (in isoform 2) | Ubiquitination | - | 31.49 | 21906983 | |
862 | Phosphorylation | SKTLMDNYEVSGGTV CCCCCCCEEECCHHH | 17.28 | 28796482 | |
863 | Phosphorylation | KTLMDNYEVSGGTVR CCCCCCEEECCHHHH | 36.14 | 27642862 | |
864 | Ubiquitination | TLMDNYEVSGGTVRE CCCCCEEECCHHHHH | 4.55 | 21963094 | |
865 | Phosphorylation | LMDNYEVSGGTVREL CCCCEEECCHHHHHH | 21.40 | 28796482 | |
868 | Phosphorylation | NYEVSGGTVRELVEA CEEECCHHHHHHHHH | 21.66 | 28796482 | |
882 | Phosphorylation | ALRQMGYTEAIEVIQ HHHHCCCHHHHHHHH | 17.14 | 22617229 | |
892 | Phosphorylation | IEVIQAASSPVKTTS HHHHHHCCCCCCCCC | 37.88 | 29255136 | |
893 | Phosphorylation | EVIQAASSPVKTTSQ HHHHHCCCCCCCCCC | 29.05 | 29255136 | |
897 | Phosphorylation | AASSPVKTTSQAHSL HCCCCCCCCCCCCCC | 31.73 | 23927012 | |
898 | Phosphorylation | ASSPVKTTSQAHSLP CCCCCCCCCCCCCCC | 17.08 | 23927012 | |
899 | Phosphorylation | SSPVKTTSQAHSLPL CCCCCCCCCCCCCCC | 30.51 | 23927012 | |
903 | Phosphorylation | KTTSQAHSLPLSPAS CCCCCCCCCCCCCCC | 34.40 | 25159151 | |
904 | Phosphorylation | TTSQAHSLPLSPAST CCCCCCCCCCCCCCH | 3.38 | 24719451 | |
907 | Phosphorylation | QAHSLPLSPASTRQQ CCCCCCCCCCCHHHH | 19.24 | 22322096 | |
908 | Phosphorylation | AHSLPLSPASTRQQI CCCCCCCCCCHHHHH | 37.60 | 24719451 | |
910 | Phosphorylation | SLPLSPASTRQQIDE CCCCCCCCHHHHHHH | 27.75 | 23927012 | |
911 | Phosphorylation | LPLSPASTRQQIDEL CCCCCCCHHHHHHHH | 34.30 | 23927012 | |
921 | Phosphorylation | QIDELRDSDSVCDSG HHHHHHHCCCCCCCC | 25.92 | 28985074 | |
923 | Phosphorylation | DELRDSDSVCDSGVE HHHHHCCCCCCCCCH | 28.70 | 10469655 | |
924 | Phosphorylation | ELRDSDSVCDSGVET HHHHCCCCCCCCCHH | 5.16 | 24719451 | |
927 | Phosphorylation | DSDSVCDSGVETSFR HCCCCCCCCCHHCCC | 39.34 | 25849741 | |
931 | Phosphorylation | VCDSGVETSFRKLSF CCCCCCHHCCCHHCC | 30.66 | 29978859 | |
932 | Phosphorylation | CDSGVETSFRKLSFT CCCCCHHCCCHHCCC | 15.00 | 29978859 | |
933 | Phosphorylation | DSGVETSFRKLSFTE CCCCHHCCCHHCCCC | 11.88 | 27251275 | |
937 | Phosphorylation | ETSFRKLSFTESLTS HHCCCHHCCCCCCCC | 32.91 | 29255136 | |
938 | Phosphorylation | TSFRKLSFTESLTSG HCCCHHCCCCCCCCC | 14.75 | 24719451 | |
939 | Phosphorylation | SFRKLSFTESLTSGA CCCHHCCCCCCCCCC | 22.68 | 25159151 | |
940 | Phosphorylation | FRKLSFTESLTSGAS CCHHCCCCCCCCCCE | 41.56 | 27251275 | |
941 | Phosphorylation | RKLSFTESLTSGASL CHHCCCCCCCCCCEE | 33.61 | 22617229 | |
942 | Phosphorylation | KLSFTESLTSGASLL HHCCCCCCCCCCEEE | 3.44 | 27251275 | |
943 | Phosphorylation | LSFTESLTSGASLLT HCCCCCCCCCCEEEE | 34.10 | 28102081 | |
944 | Phosphorylation | SFTESLTSGASLLTL CCCCCCCCCCEEEEC | 37.34 | 23403867 | |
945 | Phosphorylation | FTESLTSGASLLTLN CCCCCCCCCEEEECC | 17.60 | 27251275 | |
947 | Phosphorylation | ESLTSGASLLTLNKM CCCCCCCEEEECCCC | 27.69 | 23403867 | |
950 | Phosphorylation | TSGASLLTLNKMPHD CCCCEEEECCCCCCC | 33.31 | 23403867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
20 | S | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
328 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
337 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
337 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
337 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
337 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
903 | S | Phosphorylation | Kinase | GSK3B | P49841 | PhosphoELM |
903 | S | Phosphorylation | Kinase | GSK3B | Q9WV60 | PSP |
907 | S | Phosphorylation | Kinase | GSK3B | P49841 | PhosphoELM |
907 | S | Phosphorylation | Kinase | GSK3B | Q9WV60 | PSP |
921 | S | Phosphorylation | Kinase | IKK-FAMILY | - | GPS |
923 | S | Phosphorylation | Kinase | IKBKB | O14920 | GPS |
923 | S | Phosphorylation | Kinase | IKK-FAMILY | - | GPS |
923 | S | Phosphorylation | Kinase | CHUK | O15111 | GPS |
923 | S | Phosphorylation | Kinase | IKK_GROUP | - | PhosphoELM |
927 | S | Phosphorylation | Kinase | IKBKB | O14920 | GPS |
927 | S | Phosphorylation | Kinase | CHUK | O15111 | GPS |
927 | S | Phosphorylation | Kinase | IKK-FAMILY | - | GPS |
927 | S | Phosphorylation | Kinase | IKK_GROUP | - | PhosphoELM |
932 | S | Phosphorylation | Kinase | IKBKB | O14920 | GPS |
932 | S | Phosphorylation | Kinase | IKK-FAMILY | - | GPS |
932 | S | Phosphorylation | Kinase | CHUK | O15111 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF123 | Q5XPI4 | PMID:25860612 |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:10835356 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW11 | Q9UKB1 | PMID:25503564 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NFKB1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-893; SER-903; SER-907AND SER-937, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-907, AND MASSSPECTROMETRY. | |
"betaTrCP-mediated proteolysis of NF-kappaB1 p105 requiresphosphorylation of p105 serines 927 and 932."; Lang V., Janzen J., Fischer G.Z., Soneji Y., Beinke S., Salmeron A.,Allen H., Hay R.T., Ben-Neriah Y., Ley S.C.; Mol. Cell. Biol. 23:402-413(2003). Cited for: PHOSPHORYLATION AT SER-927 AND SER-932. | |
"Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105stability."; Demarchi F., Bertoli C., Sandy P., Schneider C.; J. Biol. Chem. 278:39583-39590(2003). Cited for: INTERACTION WITH GSK3B, PHOSPHORYLATION AT SER-903 AND SER-907, ANDMUTAGENESIS OF SER-903 AND SER-907. | |
"Direct phosphorylation of NF-kappa B1 p105 by the Ikappa B kinasecomplex on serine 927 is essential for signal-induced p105proteolysis."; Salmeron A., Janzen J., Soneji Y., Bump N., Kamens J., Allen H.,Ley S.C.; J. Biol. Chem. 276:22215-22222(2001). Cited for: PHOSPHORYLATION AT SER-927. | |
S-nitrosylation | |
Reference | PubMed |
"Inhibition of NF-kappaB DNA binding by nitric oxide."; Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T.; Nucleic Acids Res. 24:2236-2242(1996). Cited for: S-NITROSYLATION AT CYS-61, MUTAGENESIS OF CYS-61, AND MASSSPECTROMETRY. |